Sleep has wide effects on health and daily life, and understanding the connection between stress and sleep matters for many people. Christine Won, a Yale sleep specialist, describes how stress and sleep form a cycle: stress can make it harder to get restorative sleep, and poor sleep then worsens mood and memory.
Won’s interest began after she took an undergraduate course called "Sleep and Dreams." She now holds several roles at Yale School of Medicine, including professor in the section of Pulmonary, Critical Care, and Sleep Medicine and medical director of the Yale Centers for Sleep Medicine. She also returned to teach undergraduates and leads a popular course called "Mystery of Sleep."
Won highlights basic functions of sleep and gives practical advice to improve rest. She presents top tips for better sleep and explains how those steps address the sleep-stress cycle, connecting advice to health benefits.
- Restorative functions for the body
- Help with emotional regulation
- Memory consolidation
Difficult words
- restorative — helping the body recover and heal during sleep
- consolidation — process of making memories more stable
- regulation — control or management of emotional responses
- specialist — a doctor or expert in a specific field
- cycle — a series of events that repeat in order
- director — person who leads or manages a unit
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How might the sleep–stress cycle described in the article affect someone’s mood and daily activities? Give an example.
- Which of the three listed benefits of sleep (restorative body functions, emotional regulation, memory consolidation) do you think is most important for overall health? Explain your choice.
- The article says Won teaches a course called "Mystery of Sleep" and gives practical tips. Would you be interested in taking a similar course or trying her tips? Why or why not?
Related articles
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.
Few new antibiotics for children amid rising resistance
Global experts warn that few child-friendly antibiotics are being developed while antimicrobial resistance already causes millions of deaths. A 2026 Benchmark finds fewer drugs in company pipelines and a shortage of medicines for under-five children.
